logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Antibiotic optimization : An evaluation of patient safety and economic outcomes.

    Article - En anglais

    Background 

    Although numerous reports have described interventions designed to influence antibiotic utilization, to our knowledge none have been evaluated in a randomized study.

    Methods 

    Adult inpatients receiving 1 or more of 10 designated parenteral antibiotics for 3 or more days during a 3-month period were randomized to an intervention (n=141) and a control (n=111) group using an unblocked, computer-generated random number table.

    Obstetric patients and those seen in infectious disease consultation were excluded.

    The intervention group received antibiotic-related suggestions from a team consisting of an infectious disease fellow and a clinical pharmacist.

    Both groups were evaluated for clinical and microbiological outcomes as well as antibiotic utilization via prospective chart reviews and analysis of the hospital's administrative database.

    Results 

    Sixty-two (49%) of the intervention group patients received a total of 74 suggestions.

    Sixty-three (84%) of these suggestions were implemented ; the majority involved changes in antibiotic choice, dosing regimen, or route of administration.

    Per patient antibiotic charges were nearly $400 less in the intervention group vs controls (P=05).

    Almost all the savings were related to lower intravenous antibiotic charges.

    Clinical and microbiological response, antibiotic-associated toxic effects, in-hospital mortality, and readmission rates were similar for both groups. (...)

    Mots-clés Pascal : Antibiotique, Efficacité traitement, Randomisation, Coût, Evaluation, Symptomatologie, Voie administration, Facteur prédictif, Homme, Chimiothérapie, Economie santé

    Mots-clés Pascal anglais : Antibiotic, Treatment efficiency, Randomization, Costs, Evaluation, Symptomatology, Route of administration, Predictive factor, Human, Chemotherapy, Health economy

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 97-0429064

    Code Inist : 002B02S01. Création : 19/12/1997.